Burt Nabors
Memorial Sloan Kettering Cancer Center(US)University of Alabama at Birmingham(US)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Cancer, Hypoxia, and Metabolism, Brain Metastases and Treatment, Radiopharmaceutical Chemistry and Applications, Radiomics and Machine Learning in Medical Imaging
Most-Cited Works
- → Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial(2014)1,009 cited
- Human cytomegalovirus infection and expression in human malignant glioma.(2002)
- → Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma(2023)655 cited
- → Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma(2013)590 cited
- → Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology(2020)544 cited
- → Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme(2008)471 cited